Jill Buck
Förmögenhet: - $ per 2026-06-30
Förmögenhet: - $ per 2026-06-30
Jill Buck is Chief Development Officer at enGene Therapeutics, Inc. starting in 2025.
Formerly, Ms. Buck was EVP & GM Gene Therapy at Alaunos Therapeutics, Inc. Education includes an undergraduate degree from Boston College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-16 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Företagsledare/Principal | 2024-09-01 |
| Företag | Position | Slut |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
enGene Holdings, Inc.
enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån